Jul 02, 2026 8:00am EDT Vivani Announces Entry into Merger Agreement Between Wholly Owned Subsidiary Cortigent, Inc. and Nasdaq-listed ClearOne, Inc.
Jun 26, 2026 7:30am EDT Vivani Medical Announces Appointment of August J. Moretti to Board of Directors and Retirement of Dr. Dean Baker
Jun 25, 2026 7:30am EDT Vivani Medical Receives Regulatory Approval for the Initiation of SLIM-1, a Phase 1 Clinical Trial of NPM-139 Semaglutide Implant in Obesity and Chronic Weight Management
Jun 22, 2026 4:03pm EDT Vivani Medical CEO Adam Mendelsohn to Present at the 2026 BIO International Convention
May 28, 2026 8:30am EDT Vivani Medical CEO Adam Mendelsohn to Present at the Jefferies Global Healthcare Conference on June 4, 2026
May 13, 2026 4:05pm EDT Vivani Medical Reports First Quarter 2026 Financial Results and Provides Business Update
Mar 26, 2026 4:16pm EDT Vivani Medical Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
Jan 29, 2026 7:30am EST Vivani Subsidiary Cortigent Presents Promising 6-Year Early Feasibility Study Results for the Orion System at NANS 2026